KR890009976A - Synthetic peptides, compositions comprising them and methods of inducing immunity using the compositions - Google Patents

Synthetic peptides, compositions comprising them and methods of inducing immunity using the compositions Download PDF

Info

Publication number
KR890009976A
KR890009976A KR1019880000230A KR880000230A KR890009976A KR 890009976 A KR890009976 A KR 890009976A KR 1019880000230 A KR1019880000230 A KR 1019880000230A KR 880000230 A KR880000230 A KR 880000230A KR 890009976 A KR890009976 A KR 890009976A
Authority
KR
South Korea
Prior art keywords
composition
lys
leu
glu
tyr
Prior art date
Application number
KR1019880000230A
Other languages
Korean (ko)
Inventor
이이 파타로이오 마뉴엘
Original Assignee
이이 파타로이오 마뉴엘
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/135,027 external-priority patent/US4957738A/en
Application filed by 이이 파타로이오 마뉴엘 filed Critical 이이 파타로이오 마뉴엘
Publication of KR890009976A publication Critical patent/KR890009976A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음No content

Description

합성 펩티드, 이를 포함하는 조성물 및 그 조성물을 사용하여 면역성을 유도하는 방법.Synthetic peptides, compositions comprising them and methods of inducing immunity using the compositions.

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is a trivial issue, I did not include the contents of the text.

Claims (36)

하기 식의 화합물Compounds of the formula 여기서 n은 1 내지 약 10의 정수이다.Wherein n is an integer from 1 to about 10. 하기 식의 중합체 화합물The polymer compound 여기서 n은 1 내지 약 10의 정수이고 x는 2 내지 약 50의 정수이다.Where n is an integer from 1 to about 10 and x is an integer from 2 to about 50. 인간에게 적용하기에 적당한 부형제 내에 활성 성분으로서 제2항의 화합물을 포함한, 열대열말라리아 원충에 의해 유도된 말라리아에 대항하는 면역용 조성물.A composition for immunization against malaria induced by a tropical thermophilic malarial protozoa comprising the compound of claim 2 as an active ingredient in an excipient suitable for human application. 제3항에 있어서, 부형제가 인간에게 비경구 투여하기에 적당한 조성물.4. The composition of claim 3, wherein the excipient is suitable for parenteral administration to humans. 제3항의 조성물을 면역성-유도 효과량만큼 투여하는 것을 포함하는, 열대열 말라리아 원충에 의해 유도된 말라리아 대항하는 보호면역성을 유도하는 방법.A method of inducing protective immunity against malaria induced by a tropical febrile malarial protozoa, comprising administering the composition of claim 3 as much as an immunity-induced effective amount. 제5항에 있어서, 조성물이 주사에 의해 투여되는 방법.6. The method of claim 5, wherein the composition is administered by injection. 제2항에 있어서, x가 30인 화합물.The compound according to claim 2, wherein x is 30. 제2항에 있어서, n이 3인 화합물.3. The compound according to claim 2, wherein n is 3. 제3항에 있어서, x가 30인 조성물.The composition of claim 3, wherein x is 30. 제3항에 있어서, n이 3인 조성물.4. The composition of claim 3 wherein n is 3. 제5항에 있어서, x가 30인 방법.6. The method of claim 5, wherein x is 30. 제5항에 있어서, n이 3인 방법.6. The method of claim 5, wherein n is 3. 제4항에 있어서, 부형제가 수산화 알루미늄인 조성물.5. The composition of claim 4, wherein the excipient is aluminum hydroxide. 제6항에 있어서, 부형제가 수산화 알루미늄인 방법.7. The process of claim 6, wherein the excipient is aluminum hydroxide. 하기 식의 화합물Compounds of the formula 비경구 투여하기에 적당한 부형제 내에 활성성분으로서 제15항의 미합물을 포함하는, 열대열 말라리아 원충에 의해 유되된 말라리아에 대항하는 면역용 조성물.15. An immunological composition against malaria caused by a tropical thermophilic malarial protozoa comprising the micro-complex of claim 15 as an active ingredient in an excipient suitable for parenteral administration. 제16항의 조성물 면역성-유도 효과량만큼 투여하는 것을 포함하는, 열대열 말라리아 원충에 의해 유도된 말라리아에 대항하는 보호면역성을 유도하는 방법.17. A method of inducing protective immunity against malaria induced by a tropical fever malaria protozoa comprising administering an amount of the composition immunity-induced effect of claim 16. 식 Tyr-Gly-Gly-Pro-Ala-Asn-Lys-Lys-Asn-Ala-Gly-OH의 화합물.A compound of formula Tyr-Gly-Gly-Pro-Ala-Asn-Lys-Lys-Asn-Ala-Gly-OH. 식 Asp-Glu-Leu-Glu-Ala-Glu-Thr-Gln-Asn-Val-Tyr-Ala-Ala-NH2의 화합물.The compounds of the formula Asp-Glu-Leu-Glu- Ala-Glu-Thr-Gln-Asn-Val-Tyr-Ala-Ala-NH 2. 식 Tyr-Ser-Leu-Phe-Gln-Lys-Glu-Lys-Met-Val-Leu-NH2의 화합물.The compounds of the formula Tyr-Ser-Leu-Phe- Gln-Lys-Glu-Lys-Met-Val-Leu-NH 2. 식 Lys-Leu-Tyr-Gln-Ala-Gln-Tyr-Asp-Leu-Ser-Ile-OH의 화합물.A compound of the formula Lys-Leu-Tyr-Gln-Ala-Gln-Tyr-Asp-Leu-Ser-Ile-OH. 식 Lys-Lys-Phe-Thr-Lys-Asp-Glu-Asn-Lys-Pro-Asp-Glu-OH의 화합물.Lys-Phe-Thr-Lys-Asp-Glu-Asn-Lys-Pro-Asp-Glu-OH. 비경구 투여하기에 적당한 부형제내에 하기 식(Ⅰ)과 (Ⅱ)화합물등의 혼합물을 포함하는, 열대열말라리아 원충에 의해 유도된 말라리아에 대항하는 왁찐 주사용 조성물.A composition for waxy use against malaria induced by a tropical thermophilic malarial protozoa comprising a mixture of a compound of the following formula (I) and (II) or the like in an excipient suitable for parenteral administration. (I) Tyr-Gly--Gly-Pro-Ala-Asn-Lys-Lys-Asn-Ala-Gly-OH, (Ⅱ) Asp-Glu-Leu-Glu-Ala-Glu-Thr-Gln-Asn-Val-Tyr-Ala-Ala-NH2.(I) Tyr-Gly-Gly-Pro-Ala-Asn-Lys-Lys-Asn-Ala-Gly-OH, (II) Asp-Glu-Leu-Glu-Ala-Glu- -Tyr-Ala-Ala-NH 2 . 제23항에 있어서, 혼합물내에 하기 식(Ⅲ) - (Ⅴ)로 구성된 군으로부터 선택된 펩티드 화합물을 포함하는 조성물.24. The composition of claim 23, wherein the composition comprises a peptide compound selected from the group consisting of the following formula (III) - (V). (Ⅲ) Tyr-Ser-Leu-Phe-Gln-Lys-Glu-Lys-Met-Val-Leu-NH2, (Ⅳ) Lys-Leu-Tyr-Gln-Ala-Gln-Tyr-Asp-(Ⅲ) Tyr-Ser-Leu-Phe-Gln-Lys-Glu-Lys-Met-Val-Leu-NH2(Ⅳ)Lys-Leu-Tyr-Gln-Ala-Gln-Tyr-Asp-Leu-Ser-Ile-OH (Ⅴ) Lys-Lys-Phe-Thr-Lys-Asp-Glu-Asn-Lys-Pro-Asp-Glu-OH.(Ⅲ) Tyr-Ser-Leu -Phe-Gln-Lys-Glu-Lys-Met-Val-Leu-NH 2, (Ⅳ) Lys-Leu-Tyr-Gln-Ala-Gln-Tyr-Asp- (Ⅲ) Tyr-Ser-Leu-Phe- Gln-Lys-Glu-Lys-Met-Val-Leu-NH 2 (ⅳ) Lys-Leu-Tyr-Gln-Ala-Gln-Tyr-Asp-Leu-Ser-Ile-OH (V) Lys-Lys-Phe-Thr-Lys-Asp-Glu-Asn-Lys-Pro-Asp-Glu-OH. 제24항에 있어서, 펩티드 화합물이 하기식 Ⅲ의 화합물인 조성물. (Ⅲ) Tyr-Ser-Leu-Phe-Gln-Lys-Glu-Lys-Met-Val-Leu-NH2.25. The composition of claim 24, wherein the peptide compound is a compound of formula III: (Ⅲ) Tyr-Ser-Leu -Phe-Gln-Lys-Glu-Lys-Met-Val-Leu-NH 2. 제23항에 있어서, 부형체가 표준 식염수 용액인 조성물.24. The composition of claim 23, wherein the dosage form is a standard saline solution. 제23항에 있어서, 부형체가 스쿠알렌(squalene)인 조성물.24. The composition of claim 23, wherein the bulk is squalene. 제23항에 있어서, 식 Ⅰ과 Ⅱ의 화합물이 소의 혈청 알부민에 중량-대-중량으로 글루타르알데히드에 의하여 결합되어 있는 조성물.24. The composition of claim 23, wherein the compound of formula I and II is bound to bovine serum albumin in a weight-to-weight ratio by glutaraldehyde. 제23항에 있어서, 식 Ⅰ과 Ⅱ의 화합물이 공중합에 의해 결합되어 있는 조성물.24. The composition of claim 23, wherein the compounds of formula I and II are linked by copolymerization. 제25항에 있어서, 식 Ⅰ,Ⅱ및 Ⅲ의 화합물이 소의 혈청 알부민에 중량-대-중량 기준으로 글루타르알데히드에 의하여 결합되어 있는 조성물.26. The composition of claim 25, wherein the compounds of Formulas I, II, and III are bound to bovine serum albumin on a weight-to-weight basis by glutaraldehyde. 제25항에 있어서, 식 Ⅰ,Ⅱ및 Ⅲ의 화합물이 공중합에 의해 결합된 조성물.26. The composition of claim 25, wherein the compounds of Formulas I, II, and III are bound by copolymerization. 제25항에 있어서, 식 Ⅰ의 화합물 대 식Ⅱ의 화합물 대 식 Ⅲ의 화합물의 중량-대-중량비율이 약 1:1:1 내지 약 10:10:10인 조성물.26. The composition of claim 25, wherein the weight-to-weight ratio of the compound of formula I to the compound of formula II to the compound of formula III is from about 1: 1: 1 to about 10:10:10. 제32항에 있어서, 중량 대 중량 비율이 1:1:1인 조성물.33. The composition of claim 32, wherein the weight to weight ratio is 1: 1: 1. 사람에게 제25항의 조성물을 면역성-유도 효과량으로 주사하는 것을 포함하는 열대열말라리아 원충에 의해 유도된 말라리아에 대항하는 보호 면역성을 유도하는 방법.26. A method of inducing protective immunity against malaria induced by a tropical febrile malarial protozoa comprising injecting a composition of claim 25 in an amount of an immunity-inducing effect to a human. 제30항의 조성물의 면역성-유도 효과량으로 사람에게 주사하는 것을 포함하는 열대열말라리아 원충에 의해 유도된 말라리아에 대항하는 보호 면역성을 유도하는 방법.A method of inducing protective immunity against malaria induced by a tropical febrile malarial protozoa comprising injecting a human with an immunity-induced effective amount of the composition of claim 30. 제31항의 조성물의 면역성-유도 효과량으로 사람에게 주사하는 것을 포함하는 열대열말라리아 원충에 의해 유도된 말라리아에 대항하는 보호 면역성을 유도하는 방법.31. A method of inducing protective immunity against malaria induced by a tropical febrile malarial protozoa comprising injecting the human with an immunity-induced effective amount of the composition of claim 31. ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: It is disclosed by the contents of the first application.
KR1019880000230A 1987-12-29 1988-01-12 Synthetic peptides, compositions comprising them and methods of inducing immunity using the compositions KR890009976A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/135,027 US4957738A (en) 1987-01-14 1987-12-29 Protein copolymer malaria vaccine
US135027 1987-12-29

Publications (1)

Publication Number Publication Date
KR890009976A true KR890009976A (en) 1989-08-05

Family

ID=68232994

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880000230A KR890009976A (en) 1987-12-29 1988-01-12 Synthetic peptides, compositions comprising them and methods of inducing immunity using the compositions

Country Status (1)

Country Link
KR (1) KR890009976A (en)

Similar Documents

Publication Publication Date Title
KR880000098A (en) Chondroitin Sulfate Immunostimulatory Composition
AU655155B2 (en) Vaccines and vectors with liquid active principles containing an oil which can be metabolised
KR970706842A (en) Acylated Insulin Analogs
MX9304089A (en) USE OF GM-CSF AS AN ADJUVANT VACCINE.
DE69534538D1 (en) Delayed release of peptides from pharmaceutical compositions
DE59007550D1 (en) Process for the stabilization of a solid pharmaceutical preparation form of cyclic amino acids.
KR950703999A (en) MODIFIED INSULIN-LIKE GROWTH FACTORS
EA199800357A1 (en) PHARMACEUTICAL ANGIOSTATIC DIPEPTIDE COMPOSITIONS AND METHODS OF THEIR APPLICATION
SE8402560D0 (en) PHARMACEUTICAL COMPOSITION
ES2150020T3 (en) INCREASE OF THE CONCENTRATION OF CREATINE AND GLUCOGEN IN THE MUSCLE.
ATE58292T1 (en) MEDICATION CONTAINING L-DOPA.
KR940703658A (en) METHOD AND COMPOSITION FOR AMELIORATING TISSUE DAMAGE DUE TO ISCHEMIA AND REPERFUTION
KR900015749A (en) Interleukin-1 formulation
DE69837997D1 (en) LYOPHILIZABLE PHARMACEUTICAL PLAZEBO COMPOSITION, ESPECIALLY BASED ON PROTEINS OR POLYPEPTIDES, FOR THE IMMUNE OF A MEDICAMENT
FR2449697A1 (en) NOVEL MURAMYL-PEPTIDES SUBSTITUTED ON PEPTIDE NITROGEN AND MEDICAMENTS CONTAINING THEM
KR900700124A (en) Therapeutic Compositions of IL-2 and DTIC for Treatment of Melanoma
KR880008801A (en) Solution for parenteral administration
KR890009976A (en) Synthetic peptides, compositions comprising them and methods of inducing immunity using the compositions
DK270389A (en) LYOFILIZED IGM CONCENTRATE
KR900700448A (en) 1 alpha -hydroxy vitamin D analogues having unsaturated side chains
IE914436A1 (en) Use of IL-4 to enhance immune response to immunogens in vaccines
WO1992006599A3 (en) Vaccine compositions for fish
KR910005886A (en) Stabilized Leukocyte Interferon
KR910700259A (en) How T-cell Recognized Peptide Modifications Influence the Immune Response
KR960700711A (en) Medicine for treating or preventing cerebrovascular diseases

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application